- Home
- IHS vs OPK Comparison
IHS vs OPK Comparison
Compare IHS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IHS | OPK |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 921.2M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | IHS | OPK |
|---|---|---|
| Price | $8.20 | $1.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $8.11 | $2.03 |
| AVG Volume (30 Days) | 2.3M | ★ 2.4M |
| Earning Date | 03-16-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $3.90 | N/A |
| Revenue Next Year | $2.64 | $4.24 |
| P/E Ratio | $5.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.21 | $1.10 |
| 52 Week High | $8.95 | $1.75 |
Technical Indicators
Market Signals| Indicator | IHS | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 47.28 |
| Support Level | $7.82 | $1.13 |
| Resistance Level | $8.21 | $1.27 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 56.92 | 58.33 |
Price Performance
Historical ComparisonAbout IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.